Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopaminergic pathways, glial cells alterations, and behavioural correlates.
Pintori N, Castelli MP, Miliano C, Simola N, Fadda P, Fattore L, Scherma M, Ennas MG, Mostallino R, Flore G, De Felice M, Sagheddu C, Pistis M, Di Chiara G, De Luca MA. Pintori N, et al. Among authors: scherma m. Br J Pharmacol. 2021 Sep;178(17):3476-3497. doi: 10.1111/bph.15494. Epub 2021 Jun 29. Br J Pharmacol. 2021. PMID: 33837969 Free PMC article.
Cannabinoids and reward: interactions with the opioid system.
Fattore L, Cossu G, Spano MS, Deiana S, Fadda P, Scherma M, Fratta W. Fattore L, et al. Among authors: scherma m. Crit Rev Neurobiol. 2004;16(1-2):147-58. doi: 10.1615/critrevneurobiol.v16.i12.160. Crit Rev Neurobiol. 2004. PMID: 15581410 Review.
Endocannabinoid system and opioid addiction: behavioural aspects.
Fattore L, Deiana S, Spano SM, Cossu G, Fadda P, Scherma M, Fratta W. Fattore L, et al. Among authors: scherma m. Pharmacol Biochem Behav. 2005 Jun;81(2):343-59. doi: 10.1016/j.pbb.2005.01.031. Pharmacol Biochem Behav. 2005. PMID: 15935459 Review.
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.
Scherma M, Panlilio LV, Fadda P, Fattore L, Gamaleddin I, Le Foll B, Justinová Z, Mikics E, Haller J, Medalie J, Stroik J, Barnes C, Yasar S, Tanda G, Piomelli D, Fratta W, Goldberg SR. Scherma M, et al. J Pharmacol Exp Ther. 2008 Nov;327(2):482-90. doi: 10.1124/jpet.108.142224. Epub 2008 Aug 25. J Pharmacol Exp Ther. 2008. PMID: 18725543 Free PMC article.
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors.
Mascia P, Pistis M, Justinova Z, Panlilio LV, Luchicchi A, Lecca S, Scherma M, Fratta W, Fadda P, Barnes C, Redhi GH, Yasar S, Le Foll B, Tanda G, Piomelli D, Goldberg SR. Mascia P, et al. Among authors: scherma m. Biol Psychiatry. 2011 Apr 1;69(7):633-41. doi: 10.1016/j.biopsych.2010.07.009. Biol Psychiatry. 2011. PMID: 20801430 Free PMC article.
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats.
Scherma M, Justinová Z, Zanettini C, Panlilio LV, Mascia P, Fadda P, Fratta W, Makriyannis A, Vadivel SK, Gamaleddin I, Le Foll B, Goldberg SR. Scherma M, et al. Br J Pharmacol. 2012 Apr;165(8):2539-48. doi: 10.1111/j.1476-5381.2011.01467.x. Br J Pharmacol. 2012. PMID: 21557729 Free PMC article.
59 results